Luteolin offers novel therapeutic regimen in rotenone-induced Parkinson disease via modulation of TNF-α/FXMRP/serotonin/tyrosine hydroxylase signaling pathway. NJPS [Internet]. 11 april 2026 [citerad 12 april 2026];40(2). Tillgänglig vid: https://ojshostng.com/index.php/njphysiologicalsciences/article/view/4001